stockrowCytek Biosciences, Inc. (CTKB) vs OrthoPediatrics Corp. (KIDS)
- Cytek Biosciences, Inc. CTKB 5.80 +7.41%
- OrthoPediatrics Corp. KIDS 31.75 −1.46%
Cytek Biosciences, Inc. and OrthoPediatrics Corp. are both Medical Devices companies. OrthoPediatrics Corp. is the larger, with a market value of $841.3M against $701.9M — 1.2× the size. OrthoPediatrics Corp. grew revenue faster over the last twelve months: 16.2% against 5.50%. OrthoPediatrics Corp. has the higher net margin (−12.8% vs −39.1%) and the higher return on invested capital (−3.95% vs −42.1%). Across the 18 metrics below, OrthoPediatrics Corp. leads on 15 and Cytek Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | CTKB | KIDS | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 73.76% | 57.76% |
| Operating margin | (21.13%) | (9.39%) | (15.07%) |
| Net margin | (39.10%) | (12.83%) | (14.45%) |
| Free cash flow margin | (6.43%) | 1.20% | (3.88%) |
| Return on equity | (23.20%) | (9.84%) | (10.35%) |
| Return on assets | (17.26%) | (6.76%) | (17.26%) |
| Return on invested capital | (42.08%) | (3.95%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack